PERSPECTIVE TRENDS AND OPPORTUNITIES IN THE TREATMENT OF PATIENTS WITH IRRITABLE BOWEL SYNDROME
- Authors: POLUNINA T.Y.1
-
Affiliations:
- A.I. Evdokimov Moscow State Medical and Dental University
- Issue: No 2 (2016)
- Pages: 27-34
- Section: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/277315
- ID: 277315
Cite item
Open Access
Access granted
Abstract
The review deals with the analysis of the modern view of the etiopathogenesis, diagnosis and treatment of irritable bowel syndrome (IBS). The basic international criteria for the diagnosis, classification considered conventional forms of IBS. The high need for analysis of the possible causes of IBS development. The main approaches to the treatment of IBS, developed by a special committee of the American College of Gastroenterology and the Cochrane community on the basis of several large meta-analyzes and randomized clinical trials. For each of the therapeutic approaches are considered the advantages and disadvantages, as well as the level of evidence. It is concluded that pathogenetically justified approach in the treatment of IBS is the use of drugs with combined anti-inflammatory and anxiolytic activity.
Full Text
About the authors
Tatiana Yevgenievna POLUNINA
A.I. Evdokimov Moscow State Medical and Dental University
Email: poluntan@mail.ru
MD, Professor of the Department of Propedeutics of Internal Medicine and Gastroenterology 127473, Moscow, 20/1 Delegatskaya St
References
- Canavan C., West J., Card T. The epidemiology of irritable bowel syndrome. Clin. Epidemiol. 2014;6:71-80.
- Chey W.D., Kurlander J., Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015;313(9):949-58.
- Drossman D.A. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130(5):1377-90.
- Drossman D.A., Camilleri M., Mayer E.A., Whitehead W.E. AGA technical review on irritable bowel syndrome. Gastroenterology. 2002;123:2108-31.
- El-Salhy M., Gundersen D., Gilja O.H., Hatlebakk J.G., Hausken T. Is irritable bowel syndrome an organic disorder? World J. Gastroenterol. 2014;20(2):384-400.
- Kim H.S., Lim J.H., Park H., Lee S.I. Increased immunoendocrine cells in intestinal mucosa of postinfectious irritable bowel syndrome patients 3 years after acute shigella infection - an observation in a small case control study. Yonsei Med. J. 2010;51(1 ):45-51.
- Simren M., Barbara G., Flint H.J., Spiegel B.M., Spiller R.C., Vanner S., Verdu E.F., Whorwell P.J., Zoetendal E.G. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut. 2012;62:159-76.
- Spiegel B.M., Farid M., Esrailian E., Talley J., Chang L. Is irritable bowel syndrome a diagnosis of exclusion? a survey of primary care providers, gastroenterologists, and IBS experts. Am. J. Gastroenterol. 2010;105(4):848-58.
- Ивашкин В.Т., Шелыгин Ю.А., Баранская Е.К., Белоусова Е.А., Васильев С.В., Головенко О.В., Головенко А.О., Григорьев Е.Г., Костенко Н.В., Кашников В.Н., Куликовский В.Ф., Лапина Т.Л., Маев И.В., Полуэктова Е.А., Румянцев В.Г., Тимербулатов В.М., Тихонов А.А., Трухманов А.С., Фоменко О.Ю., Халиф И.Л., Хубезов Д.А., Чашкова Е.Ю., Чибисов Г.И., Шептулин А.А., Шифрин О.С., Яновой В.В. Клинические рекомендации Российской гастроэнтерологической ассоциации, Ассоциации колопроктологов России по диагностике и лечению больных с синдромом раздраженного кишечника. Рос. журн. гастроэнтерол., гепатол., колопроктол. 2014;2:92-101.
- Маев И.В., Черемушкин С.В. Синдром раздраженного кишечника: пособие для врачей - М.: Форте принт, 2012. 52 с
- Маев И.В., Черемушкин С.В., Кучерявый Ю.А., Черемушкина Н.В. Фармакотерапия синдрома раздраженного кишечника с позиций доказательной медицины. Терапевтический архив. 2015;2:4-10
- Маев И.В., Кучерявый Ю.А., Черемушкин С.В. Эволюция представлений о синдроме раздраженного кишечника. М.: Форте Принт, 2013. 80 с
Supplementary files
